These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8768297)
1. [Autoimmunity and glutamate decarboxylase antibodies in the pathogenesis of type I diabetes mellitus in experimental and clinical practice]. Kucera P; Andĕl M; Treslová L Vnitr Lek; 1996 May; 42(5):359-67. PubMed ID: 8768297 [TBL] [Abstract][Full Text] [Related]
2. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. Hummel M; Durinovic-Bello I; Ziegler AG J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982 [TBL] [Abstract][Full Text] [Related]
3. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus. Davison LJ; Weenink SM; Christie MR; Herrtage ME; Catchpole B Vet Immunol Immunopathol; 2008 Nov; 126(1-2):83-90. PubMed ID: 18706702 [TBL] [Abstract][Full Text] [Related]
5. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives]. Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin variable gene analysis of human autoantibodies reveals antigen-driven immune response to glutamate decarboxylase in type 1 diabetes mellitus. Richter W; Jury KM; Loeffler D; Manfras BJ; Eiermann TH; Boehm BO Eur J Immunol; 1995 Jun; 25(6):1703-12. PubMed ID: 7614998 [TBL] [Abstract][Full Text] [Related]
7. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878 [TBL] [Abstract][Full Text] [Related]
9. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study. Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984 [TBL] [Abstract][Full Text] [Related]
10. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes]. Hermann R; Gombos Z; Gyürüs E; Soltész G Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382 [TBL] [Abstract][Full Text] [Related]
11. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A]. Martinka E; Ocenásová A; Straková J; Mokán M Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228 [TBL] [Abstract][Full Text] [Related]
12. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus. Tsirogianni A; Pipi E; Soufleros K Autoimmun Rev; 2009 Jul; 8(8):687-91. PubMed ID: 19217947 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital. Römkens TE; Kusters GC; Netea MG; Netten PM Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158 [TBL] [Abstract][Full Text] [Related]
14. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase. Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434 [TBL] [Abstract][Full Text] [Related]
15. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes. Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients. Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671 [TBL] [Abstract][Full Text] [Related]
17. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient. Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300 [TBL] [Abstract][Full Text] [Related]
18. The possible role of autoimmunity in the pathogenesis of diabetes in B-thalassemia major. Monge L; Pinach S; Caramellino L; Bertero MT; Dall'omo A; Carta Q Diabetes Metab; 2001 Apr; 27(2 Pt 1):149-54. PubMed ID: 11353881 [TBL] [Abstract][Full Text] [Related]